Department of Endocrinology, Erciyes University Medical School, 38039 Kayseri, Turkey.
Pituitary. 2013 Mar;16(1):76-82. doi: 10.1007/s11102-012-0377-9.
Subarachnoid haemorrhage (SAH) is known to be related to pituitary dysfuntion in retrospective and short-term prospective studies. We aimed to investigate pituitary functions in patients with SAH in longer follow-up periods to demonstrate if pituitary hormone deficiencies recover, persist or new hormone deficiencies occur. Twenty patients with SAH, who were followed up for 3 years, were included in the present study. Patients were evaluated with basal hormone levels and glucagon stimulation test (GST).Serum basal cortisol and adrenocorticotropic hormone (ACTH) levels were found to be significantly elevated at 3rd year of SAH compared to 1st year. Other basal hormone levels at 3rd year did not show a significant change from the levels found at 1st year. One of the patients had ACTH deficiency at 1st year of SAH and recovered at 3rd year. Growth hormone (GH) deficiency, according to GST,was diagnosed in 4 patients. One patient with GH deficiency at first year was still deficient, 3 of them recovered and 3 patients were found to have new-onset GH deficiency 3 years after SAH. SAH is associated with anterior pituitary dysfunction and GH is the most frequently found deficient hormone in the patients. Although one year after SAH seems to be an appropriate time for the evaluation of pituitary functions, further follow-up may be required at least in some cases due to recovered and new-onset hormone deficiencies at 3rd year of SAH.
蛛网膜下腔出血 (SAH) 在回顾性和短期前瞻性研究中已知与垂体功能障碍有关。我们旨在通过对 SAH 患者进行更长时间的随访,以证明垂体激素缺乏是否恢复、持续存在或出现新的激素缺乏,来研究 SAH 患者的垂体功能。本研究纳入了 20 例 SAH 患者,随访时间为 3 年。通过基础激素水平和胰高血糖素刺激试验 (GST) 对患者进行评估。与第 1 年相比,第 3 年 SAH 患者血清基础皮质醇和促肾上腺皮质激素 (ACTH) 水平显著升高。第 3 年的其他基础激素水平与第 1 年相比没有明显变化。1 例患者在 SAH 的第 1 年存在 ACTH 缺乏,第 3 年恢复。根据 GST 诊断 4 例患者存在生长激素 (GH) 缺乏。第 1 年 GH 缺乏的 1 例患者仍存在缺乏,3 例患者恢复,3 例患者在 SAH 后 3 年出现新的 GH 缺乏。SAH 与垂体前叶功能障碍有关,GH 是患者中最常发现的缺乏激素。尽管在 SAH 后 1 年进行垂体功能评估似乎是合适的,但由于在第 3 年恢复和出现新的激素缺乏,在某些情况下可能需要进一步随访。